• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗方式对腹膜透析和血液透析患者感染相关住院率的影响。

The impact of treatment modality on infection-related hospitalization rates in peritoneal dialysis and hemodialysis patients.

机构信息

Infection Prevention and Control, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

出版信息

Perit Dial Int. 2011 Jul-Aug;31(4):440-9. doi: 10.3747/pdi.2009.00224. Epub 2010 Jul 29.

DOI:10.3747/pdi.2009.00224
PMID:20671104
Abstract

BACKGROUND AND OBJECTIVES

Infection is a major cause of morbidity and mortality in the dialysis population. This study compares the rates of infection-related hospitalization (IRH) in incident chronic dialysis patients initiating outpatient peritoneal dialysis (PD) and hemodialysis (HD).

METHODS AND PATIENTS

This was a retrospective cohort study at the dialysis program of a tertiary-care center in Toronto, Canada. Incident chronic dialysis patients that were eligible for both PD and HD and started outpatient dialysis between 1 January 2004 and 31 August 2008 were included. Dialysis modality was assigned at the start of outpatient dialysis treatment. All hospital admissions were reviewed and incidence of IRH was compared between PD and HD using Poisson regression.

RESULTS

Of 264 incident chronic dialysis patients, 168 (64%) were eligible for both treatment modalities: 71 (42%) started outpatient PD and 97 (58%) started outpatient HD. The unadjusted and adjusted incidence rate ratios (IRR) of IRH did not differ significantly between PD and HD: 1.23 [95% confidence interval (CI) 0.65-2.32, p=0.37] and 1.14 (95% CI 0.58-2.23, p=0.71) respectively. There was no difference between PD and HD in the risk of access loss (28% vs 35%, p=0.73), modality change (22% vs 0%, p=0.10), or death (17% vs 6%, p=0.60) following hospitalization for infection. Patients starting outpatient treatment on PD versus HD were more likely to be hospitalized for peritonitis (IRR 3.20, 95% CI 1.16-9.09; p=0.029) and there was a trend for fewer hospitalizations for bacteremia (IRR 0.19, 95% CI 0.028-1.30; p=0.091). The risk of IRH did not differ between PD and HD in the subgroup of patients that received adequate predialysis care (IRR 1.16, 95% CI 0.59-2.27; p=0.67) or when patients starting outpatient HD with a central venous catheter were excluded (IRR 1.52, 95% CI 0.53-4.37; p=0.44).

CONCLUSIONS

Patients that initiate outpatient peritoneal dialysis do not have a significantly increased risk of infection-related hospitalization compared to those that initiate outpatient hemodialysis.

摘要

背景与目的

感染是透析人群发病和死亡的主要原因。本研究比较了开始门诊腹膜透析(PD)和血液透析(HD)的慢性透析患者中与感染相关的住院(IRH)的发生率。

方法与患者

这是在加拿大多伦多一家三级护理中心的透析项目中进行的回顾性队列研究。符合 PD 和 HD 条件且 2004 年 1 月 1 日至 2008 年 8 月 31 日开始门诊透析的慢性透析患者均纳入研究。在开始门诊透析治疗时,分配透析方式。对所有住院治疗进行审查,并使用泊松回归比较 PD 和 HD 之间的 IRH 发生率。

结果

在 264 名新诊断的慢性透析患者中,有 168 名(64%)适合两种治疗方式:71 名(42%)开始门诊 PD,97 名(58%)开始门诊 HD。PD 和 HD 之间的未调整和调整后的 IRH 发生率比值(IRR)无显著差异:1.23[95%置信区间(CI)0.65-2.32,p=0.37]和 1.14(95%CI 0.58-2.23,p=0.71)。PD 和 HD 之间在因感染住院后的通路损失(28%vs35%,p=0.73)、方式改变(22%vs0%,p=0.10)或死亡(17%vs6%,p=0.60)方面无差异。与开始门诊 HD 治疗的患者相比,开始门诊 PD 治疗的患者更有可能因腹膜炎(IRR 3.20,95%CI 1.16-9.09;p=0.029)而住院,且因菌血症(IRR 0.19,95%CI 0.028-1.30;p=0.091)而住院的趋势较低。在接受充分透析前护理的患者亚组中(IRR 1.16,95%CI 0.59-2.27;p=0.67)或排除开始门诊 HD 时伴有中央静脉导管的患者(IRR 1.52,95%CI 0.53-4.37;p=0.44)时,PD 和 HD 之间的 IRH 风险无差异。

结论

与开始门诊血液透析的患者相比,开始门诊腹膜透析的患者发生与感染相关的住院治疗的风险并未显著增加。

相似文献

1
The impact of treatment modality on infection-related hospitalization rates in peritoneal dialysis and hemodialysis patients.治疗方式对腹膜透析和血液透析患者感染相关住院率的影响。
Perit Dial Int. 2011 Jul-Aug;31(4):440-9. doi: 10.3747/pdi.2009.00224. Epub 2010 Jul 29.
2
Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients.新发性血液透析患者与腹膜透析患者感染并发症的比较。
Clin J Am Soc Nephrol. 2006 Nov;1(6):1226-33. doi: 10.2215/CJN.01230406. Epub 2006 Oct 11.
3
Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.急性非计划性腹膜透析与血液透析的可比结局。
Nephrol Dial Transplant. 2012 Jan;27(1):375-80. doi: 10.1093/ndt/gfr262. Epub 2011 May 28.
4
Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis.透析模式与感染相关住院风险的关联:倾向评分匹配队列分析。
Clin J Am Soc Nephrol. 2012 Oct;7(10):1598-605. doi: 10.2215/CJN.00440112. Epub 2012 Aug 16.
5
Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.适合两种治疗模式的患者中,血液透析与腹膜透析患者的生存比较。
Am J Kidney Dis. 2018 Mar;71(3):344-351. doi: 10.1053/j.ajkd.2017.08.028. Epub 2017 Nov 22.
6
First-year outcomes of incident peritoneal dialysis patients in the United States.美国新入组腹膜透析患者的 1 年转归。
Am J Kidney Dis. 2014 Nov;64(5):761-9. doi: 10.1053/j.ajkd.2014.04.025. Epub 2014 Jun 11.
7
Dialysis Modality and Readmission Following Hospital Discharge: A Population-Based Cohort Study.透析方式与出院后再入院:一项基于人群的队列研究。
Am J Kidney Dis. 2017 Jul;70(1):11-20. doi: 10.1053/j.ajkd.2016.10.020. Epub 2017 Jan 6.
8
Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study.与腹膜透析相比,使用动静脉瘘或中心静脉导管开始血液透析的效果:一项回顾性队列研究。
BMC Nephrol. 2012 Aug 23;13:88. doi: 10.1186/1471-2369-13-88.
9
Association between Dialysis Modality and Infectious Diseases: Peritoneal Dialysis versus Hemodialysis.透析方式与感染性疾病的关联:腹膜透析与血液透析。
Blood Purif. 2021;50(3):370-379. doi: 10.1159/000511041. Epub 2020 Oct 29.
10
Impact of Assisted Peritoneal Dialysis Modality on Outcomes: A Cohort Study of the French Language Peritoneal Dialysis Registry.辅助性腹膜透析模式对结局的影响:法国腹膜透析登记处的队列研究。
Am J Nephrol. 2018;48(6):425-433. doi: 10.1159/000494664. Epub 2018 Nov 21.

引用本文的文献

1
Severe infections in peritoneal dialysis and home hemodialysis patients: An inception cohort study.腹膜透析和居家血液透析患者的严重感染:一项发病队列研究。
PLoS One. 2023 Jun 14;18(6):e0286579. doi: 10.1371/journal.pone.0286579. eCollection 2023.
2
Differences in hospitalisation between peritoneal dialysis and haemodialysis patients.腹膜透析和血液透析患者住院情况的差异。
Eur J Clin Invest. 2022 Jun;52(6):e13758. doi: 10.1111/eci.13758. Epub 2022 Feb 15.
3
Starting Dialysis on Time, At Home on the Right Therapy (START): Description of an Intervention to Increase the Safe and Effective Use of Peritoneal Dialysis.
按时在家开始正确疗法的透析(START):一项旨在提高腹膜透析安全有效使用的干预措施描述
Can J Kidney Health Dis. 2021 Mar 31;8:20543581211003764. doi: 10.1177/20543581211003764. eCollection 2021.
4
Clinical outcomes of infection-related hospitalization in incident peritoneal dialysis patients.新发腹膜透析患者感染相关住院的临床结局
Kidney Res Clin Pract. 2020 Dec 31;39(4):460-468. doi: 10.23876/j.krcp.20.069.
5
Risk of death after first-time blood stream infection in incident dialysis patients with specific consideration on vascular access and comorbidity.首次发生血源性感染的透析患者的死亡风险,尤其考虑血管通路和合并症。
BMC Infect Dis. 2018 Dec 20;18(1):688. doi: 10.1186/s12879-018-3594-7.
6
Hospitalizations in Dialysis Patients in Canada: A National Cohort Study.加拿大透析患者的住院情况:一项全国队列研究。
Can J Kidney Health Dis. 2018 Jun 1;5:2054358118780372. doi: 10.1177/2054358118780372. eCollection 2018.
7
More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model.更多地使用腹膜透析可带来显著的成本节约:一项系统评价与卫生经济决策模型
J Clin Med Res. 2017 Feb;9(2):104-116. doi: 10.14740/jocmr2817w. Epub 2016 Dec 31.
8
Septic shock in chronic dialysis patients: clinical characteristics, antimicrobial therapy and mortality.慢性透析患者的败血症性休克:临床特征、抗菌治疗和死亡率。
Intensive Care Med. 2016 Feb;42(2):222-32. doi: 10.1007/s00134-015-4147-9. Epub 2015 Nov 25.
9
Peritoneal dialysis outcomes of Indigenous Australian patients of remote Kimberley origin.来自偏远金伯利地区的澳大利亚原住民患者的腹膜透析治疗结果。
Aust J Rural Health. 2014 Jun;22(3):101-8. doi: 10.1111/ajr.12086.
10
Peritoneal dialysis associated infections: An update on diagnosis and management.腹膜透析相关感染:诊断与管理的最新进展
World J Nephrol. 2012 Aug 6;1(4):106-22. doi: 10.5527/wjn.v1.i4.106.